Published by Global Banking & Finance Review®
Posted on February 12, 2025
2 min readLast updated: January 26, 2026
Add as preferred source on Google
EssilorLuxottica's operating profit rose 9.4% in 2022, aligning with forecasts. The company targets mid-single-digit growth and expands into new sectors.
MILAN (Reuters) - Eyewear maker EssilorLuxottica said on Wednesday its adjusted operating profit rose 9.4% last year, to 4.4 billion euros ($4.6 billion), broadly in line with analysts' expectations.
Revenues at the group, whose brands include Ray-Ban, rose 9.2% at constant exchange rates in the fourth quarter, accelerating compared the third quarter and bringing the total revenues for the year to 26.5 billion euros, a touch above a 26.4 billion euros analysts forecast according to LSEG data.
"We celebrate... our fourth consecutive year of top line growth on track with our targets including a strong acceleration in the fourth quarter, with all regions and businesses contributing to our momentum," said Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO.
The managers added that the Franco-Italian group remains on track with its long-term targets.
The company confirmed its target of mid-single-digit annual revenue growth from 2022 to 2026 at constant exchange rates, noting it targets a range of 27-28 billion euros by the end of the period.
It also confirmed it expects to achieve an adjusted operating profit equal to 19-20% of revenues by 2026, from 17% at the end of last year.
Although the company still generates most of its revenues from the sale of frames and lenses, it is looking to expand into new sectors such as medical and high-tech.
The group said that it had sold 2 million units of Ray-Ban Meta smartglasses since their launch, with a strong acceleration in 2024. ($1 = 0.9638 euros)
(Reporting by Elisa Anzolin; Editing by Keith Weir)
The article discusses EssilorLuxottica's operating profit growth and future targets.
Revenues reached 26.5 billion euros in 2022, slightly above forecasts.
The company plans to expand into medical and high-tech sectors and aims for mid-single-digit growth.
Explore more articles in the Finance category
